Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat

Cancer Prev Res (Phila). 2011 Oct;4(10):1675-85. doi: 10.1158/1940-6207.CAPR-11-0175. Epub 2011 Aug 2.

Abstract

This study investigated the effect of a broad range of dietary ratios of n-3:n-6 fatty acids on mammary gland density and mammary cancer risk. Cancer was induced in female rats by N-methyl-N-nitrosourea. Purified diet that provided 30% of dietary kilocalories from fat was formulated to contain ratios of n-3:n-6 fatty acids from 25:1 to 1:25. Mammary gland density was determined by digital analysis, fatty acids by gas chromatography/flame ionization detection, and other plasma analytes via ELISA. Mammary gland density was reduced dose dependently at n-3:n-6 ratios from 1:1 to 25:1 (r = -0.477, P = 0.038), with a 20.3% decrease of mammary gland density between n-3:n-6 of 1:1 versus 25:1, P < 0.001. Mammary carcinogenesis was inhibited in the absence or presence of tamoxifen (1 mg/kg diet) in a manner predicted by mammary gland density. Plasma n-3 fatty acid concentrations failed to increase above an n-3:n-6 ratio of 5:1, and changes in specific plasma n-3 or n-6 fatty acids were not predictive of mammary gland density or cancer inhibitory activity. A strong reciprocal effect of the n-3:n-6 ratio on plasma leptin (decreased, P = 0.005) and adiponectin (increased, P < 0.001) was observed indicating adipose tissue function was modulated. However, neither cytokine was predictive of mammary gland density. Plasma insulin-like growth factor I (IGF-I) decreased with increasing dietary n-3:n-6 ratio (P = 0.004) and was predictive of the changes in mammary gland density (r = 0.362, P < 0.005). These findings indicate that (i) mammary gland density predicted the carcinogenic response, (ii) the n-3:n-6 ratio exerts effects in the presence or absence of hormonal regulation of carcinogenesis, and (iii) signaling pathways regulated by IGF-I are potential targets for further mechanistic investigation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism
  • Alkylating Agents / toxicity
  • Animals
  • Antineoplastic Agents, Hormonal / pharmacology
  • Cytokines / blood
  • Diet*
  • Enzyme-Linked Immunosorbent Assay
  • Fatty Acids, Omega-3 / metabolism*
  • Fatty Acids, Omega-6 / metabolism*
  • Female
  • Insulin-Like Growth Factor I / metabolism
  • Mammary Glands, Animal / drug effects*
  • Mammary Glands, Animal / pathology*
  • Mammary Neoplasms, Experimental / chemically induced
  • Mammary Neoplasms, Experimental / prevention & control*
  • Methylnitrosourea / toxicity
  • Rats
  • Rats, Sprague-Dawley
  • Tamoxifen / pharmacology

Substances

  • Alkylating Agents
  • Antineoplastic Agents, Hormonal
  • Cytokines
  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • Tamoxifen
  • Insulin-Like Growth Factor I
  • Methylnitrosourea